Reckon the entitlement profit taking almost done now. Normal trading and no doubt another spike on the next bit of good news (presuming the next news good). Singapore/Vietnamese pprovals; A*Star trials commencing; SingHealth research collaboration; what's next I wonder? Some news on Temasek backed Innoventure partnership? Hopefully good news.
One could be forgiven for expecting A*Star might be keen to have further bio-tech expansion success into Chinese mkts:
I can't say recent developments may deter Innoventure, though perhaps OSX's recent capital crisis might have seen them set harder negotiating terms. Time will tell....
OSX Price at posting:
7.5¢ Sentiment: Buy Disclosure: Held
